- Conditions
- Cataract
- Interventions
- ReSTOR +3, Crystalens HD, Crystalens AO
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 132 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2009
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 145–168
of 310
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Glaucoma, Cataracts
- Interventions
- 2 Site procedure- Phacoemulsification/IOL and Trabeculectomy
- Procedure
- Lead sponsor
- Lahey Clinic
- Other
- Eligibility
- Not listed
- Enrollment
- 95 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1998 – 2009
- U.S. locations
- 1
- States / cities
- Burlington, Massachusetts
- Conditions
- Cataract
- Interventions
- Alcon Vivity or Vivity Toric IOL
- Device
- Lead sponsor
- Research Insight LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 3
- States / cities
- Laguna Hills, California • Palm City, Florida • Edwardsville, Illinois
- Conditions
- Cataracts
- Interventions
- Acrysof IQ (SN60WF) IOL
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2010
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Aphakia, Astigmatism, Presbyopia
- Interventions
- Clareon Vivity IOL - Non Toric, Clareon Vivity IOL - Toric, Clareon PanOptix Trifocal IOL - Non Toric, Clareon PanOptix Trifocal IOL - Toric
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 470 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 6
- States / cities
- Torrance, California • Jacksonville, Florida • Liverpool, New York + 3 more
- Conditions
- Cataract
- Interventions
- Clareon monofocal Intraocular lens (toric and non-toric models)
- Device
- Lead sponsor
- Eye Consultants of Atlanta
- Other
- Eligibility
- 45 Years and older
- Enrollment
- 34 participants
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Cataract
- Interventions
- enVista MX60E, enVista MX60EF
- Device
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 501 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2023
- U.S. locations
- 23
- States / cities
- Fayetteville, Arkansas • Garden Grove, California • Northridge, California + 19 more
- Conditions
- Primary Open Angle Glaucoma
- Interventions
- Hydrus Aqueous Implant, Cataract surgery
- Device · Procedure
- Lead sponsor
- Ivantis, Inc.
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 1,143 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2020
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Fayetteville, Arkansas + 23 more
- Conditions
- Cataract
- Interventions
- AcrySof® Toric IOL
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 40 Years to 80 Years
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Dysphotopsia, Posterior Capsule Opacification, Visual Acuity, Visual Function, Contrast Sensitivity
- Interventions
- None-placebo
- Other
- Lead sponsor
- Dr. Daniel H. Chang, MD
- Other
- Eligibility
- 22 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Bakersfield, California
- Conditions
- Age Related Cataracts
- Interventions
- Clareon PanOptix or PanOptix Toric IOLs, Comparable multifocal IOL
- Device
- Lead sponsor
- Argus Research Center, Inc.
- Other
- Eligibility
- Not listed
- Enrollment
- 290 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 3
- States / cities
- Torrance, California • Cape Coral, Florida • Gainesville, Georgia
- Conditions
- Lymphoma, Small Intestine Cancer
- Interventions
- radionuclide imaging, indium In 111-labeled autologous peripheral blood mononuclear cells, indium In 111-labeled autologous polymorphonuclear leukocytes
- Procedure · Radiation
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2012
- U.S. locations
- 2
- States / cities
- Iowa City, Iowa • Rochester, Minnesota
- Conditions
- Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
- Interventions
- imetelstat sodium, laboratory biomarker analysis, pharmacological study
- Drug · Other
- Lead sponsor
- Children's Oncology Group
- Network
- Eligibility
- 1 Year to 21 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 21
- States / cities
- Birmingham, Alabama • Orange, California • San Francisco, California + 18 more
- Conditions
- Cataract
- Interventions
- ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power Intraocular Lens, ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Cataract Extraction
- Interventions
- Cataract surgery with Perfect Capsule and Sodium Chloride
- Procedure
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 4 Years to 18 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- Cataract, Glaucoma, Ocular Hypertension
- Interventions
- Bimatoprost Implant System, SpyGlass IOL, Timolol Maleate Ophthalmic Solution, 0.5%, Commercial IOL
- Drug · Device
- Lead sponsor
- SpyGlass Pharma, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Cataract
- Interventions
- Aspheric Acrysof ReSTOR intraocular lens
- Device
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- Cataract
- Interventions
- Dexycu, Standard of Care post operative eye drops (steroid, antibiotic, NSAID)
- Drug
- Lead sponsor
- The Eye Institute of West Florida
- Other
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Largo, Florida
- Conditions
- Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis, Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Pemetrexed
- Drug
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2011
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Bladder Cancer, Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Prostate Cancer, Testicular Germ Cell Tumor, Tobacco Use Disorder, Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- nicotine, Usual Care
- Drug · Behavioral
- Lead sponsor
- Eastern Cooperative Oncology Group
- Network
- Eligibility
- 19 Years to 120 Years
- Enrollment
- 434 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 1990
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Cataract
- Interventions
- Tecnis Multifocal 1-Piece IOL
- Device
- Lead sponsor
- Dell Laser Consultants
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Cataracts, Astigmatism
- Interventions
- T3, T4, T5
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 144 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2007
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Cataract
- Interventions
- Clareon PanOptix Pro IOL
- Device
- Lead sponsor
- Juliette Eye Institute Research Center
- Other
- Eligibility
- 45 Years and older
- Enrollment
- 40 participants
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Albuquerque, New Mexico
- Conditions
- Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
- Interventions
- busulfan, cyclophosphamide, cytarabine, allogeneic bone marrow transplantation
- Drug · Procedure
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- Up to 55 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1992 – 2000
- U.S. locations
- 1
- States / cities
- New York, New York